NEUROENDOCRINE TUMOURS: THE CUTTING EDGE AND A GLIMPSE INTO THE FUTURE
Clinical trial endpoints relevant to patients/society for rare tumours and conclusions
I. Chau
Clinical trial endpoints relevant to patients/society for rare tumours and conclusions
I. Chau